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Children with congenital heart disease (CHD) remain at risk for neurodevelopmental impairment despite improved peri- and 
intraoperative care. Our prospective cohort study aimed to determine the relationship between perioperative brain volumes 
and neurodevelopmental outcome in neonates with severe CHD. Pre- and postoperative cerebral MRI was acquired in term 
born neonates with CHD undergoing neonatal cardiopulmonary bypass surgery. Brain volumes were measured using an atlas 
prior based automated method. One-year outcome was assessed with the Bayley-III. CHD infants (n=77) had lower pre- and 
postoperative total and regional brain volumes compared to controls (n=44, all p<0.01). CHD infants had poorer cognitive 
and motor outcome (p≤0.0001) and a trend towards lower language composite score compared to controls (p=0.06). The total 
and selected regional postoperative brain volumes predicted cognitive and language outcome (all p<0.04). This association 
was independent of length of intensive care unit stay for total, cortical, temporal, frontal and cerebellar volumes. In CHD 
neonates undergoing cardiopulmonary bypass surgery, pre- and postoperative brain volumes are reduced, and postoperative 
brain volumes predict cognitive and language outcome at one year. Reduced cerebral volumes in CHD patients could serve 
as a biomarker for impaired outcome. 
Background 
Congenital heart disease (CHD) is the most common congenital 
malformation in childhood1. Despite dramatic improvements in peri- 
and intraoperative care that have led to an increase in survival rates, 
children with severe CHD remain at risk for neurodevelopmental im-
pairment 1,2. Cognitive, language and motor functions may be 
impaired during early childhood 3-5, but impairments often persist and 
include deficits in visuomotor and executive functions in adolescence 
6,7. Cerebral magnetic resonance imaging (MRI) studies have shown a 
high incidence of usually small pre- 2,8,9 and postoperative white mat-
ter injuries (WMI) 2,10 and strokes 2,11,12 in neonates with CHD, and 
delayed brain maturation and growth has also been described in this 
population 13-16. Volumetric analyses of neonatal cerebral MRI exami-
nations have revealed that infants with severe CHD have smaller brain 
volumes compared to healthy born infants 8,17, with all brain regions 
being equally affected 17. There is mounting evidence that delayed 
brain maturation and brain injuries in neonates with CHD are associ-
ated with poorer neurodevelopmental outcome. Recently published 
studies have reported that new postoperative cerebral lesions on MRI 
correlate with lower cognitive and language scores at one year 18. The 
white matter seems particularly predictive of early childhood motor 12 
and school-age cognitive outcome 19. Moreover, delayed brain matu-
ration has been shown to predict 2-year neurodevelopmental 
outcome 11. While total brain volume reduction has been shown to 
correlate with neurobehaviour prior to neonatal surgery (4), the role 
of regional brain volumes in predicting neurodevelopmental outcome 
in early childhood is yet unknown. Elucidating the association between 
regional brain volume reduction and specific neurodevelopmental 
outcomes may enable us to determine the antecedents of later altered 
development 17. 
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The primary aim of our study was to examine the predictive value 
of pre- and postoperative total and regional brain volumes for one-
year neurodevelopmental outcome in children with severe CHD, and 
to investigate if such an effect is independent of patient-specific (e.g. 
sex, severity of CHD, socioeconomic status (SES)) and perioperative 
risk factors. A secondary aim was to examine brain growth between 
pre- and postoperative MRI in infants with CHD in comparison to 
cross-sectional brain volumes from healthy infants, in order to assess 
if brain growth is delayed in children with CHD, and whether the delay 
is predictive of neurodevelopmental outcome. We hypothesized that 
lower regional brain volumes would be associated with poorer neuro-
developmental outcome independent of patient-specific and 
perioperative risk factors. We further hypothesized that brain growth 
would be delayed in CHD infants, and that the delay would be predic-
tive of poorer outcome. 
Methods 
Patient population. This study is part of an ongoing prospective cohort 
study investigating neurodevelopmental outcome and the timing of 
cerebral injuries in infants operated for CHD 17. Between December 
2009 and August 2016, term born neonates (> 36 week gestation) with 
severe CHD undergoing cardiopulmonary bypass surgery (CPB) were 
consecutively enrolled in the study. Written informed consent was 
provided from the parents or legal guardians and the study was ap-
proved by the regional ethics committee of the Canton Zurich 
(Kantonale Ethikkommission Zürich). The study was carried out in ac-
cordance with the principles enunciated in the Declaration of Helsinki 
and the guidelines of Good Clinical Practice. Neonates were enrolled 
in the study after being admitted to the paediatric cardiac intensive 
care unit (ICU). Neonates with a suspected or confirmed genetic disor-
der or syndrome were excluded. Infants included in the study 
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underwent cerebral MRI before and after surgery and a neurodevel-
opmental assessment at 12 months of age, using the Bayley Scales of 
Infant and Toddler Development, Third Edition (Bayley-III). The Bay-
ley–III assesses different developmental domains and provides three 
main composite scores: the cognitive composite score (CCS), the lan-
guage composite score (LCS) and the motor composite score (MCS) 
with a mean score of 100 and a standard deviation of +/- 15. The Bay-
ley-III was administered by trained developmental paediatricians. SES 
was estimated based on maternal education and paternal occupation 
20 yielding a score ranging from 2-12 with higher scores indicating 
higher SES.  
Healthy term born infants were recruited as controls from the well-
baby maternity unit of the University Hospital Zurich. None of the con-
trol infants had any cerebral lesions on MRI, and none of the controls 
had been admitted to the neonatal unit. 
Surgical procedure. Cardiac surgery included biventricular repair by 
arterial switch or Rastelli operation for patients with dextro-transpo-
sition of the great arteries (dTGA), complex aortic arch surgery, aorto-
pulmonary shunt procedure and early Fallot repair. As univentricular 
palliation Norwood-type stage I palliation for patients with hypoplastic 
left heart syndrome and other forms of univentricular physiology with 
a hypoplastic aortic arch was performed 17.  
Cerebral MRI and image post processing. Neonatal cerebral MRI was 
performed during natural sleep on a 3.0 T clinical MRI scanner using 
an 8-channel head coil (GE Signa MR750). Ear plugs (attenuation: 24 
dB; Earsoft; Aearo) and Minimuffs (attenuation: 7 dB; Natus) were ap-
plied for noise protection. Oxygen saturation was monitored during 
scanning, and a neonatologist and a neonatal nurse were present dur-
ing the MRI investigation. 2D fast spin-echo T2-weighted anatomical 
sequences were acquired in axial, sagittal and coronal planes. The se-
quence parameters for the anatomical MRI were the following. TE/TR: 
97/5900 ms, flip angle: 90°, number of averages: 2, acquisition matrix: 
512 * 320, in-plane voxel dimensions: 0.7 * 0.7 mm resampled to 0.35 
* 0.35 mm, slice thickness: 2.5 mm, slice gap: 0.2 mm. The anatomical 
MRI was followed by diffusion tensor imaging, proton MR spectros-
copy and arterial spin labelling sequences. Further details about the 
imaging setting and MRI sequence parameters for this ongoing study 
have been reported previously 10.  
Each MRI scan was scored for the presence of brain abnormalities by 
a trained neuroradiologist blinded to all clinical characteristics 10. Dur-
ing the course of the study, a scanner software update was performed. 
Therefore, the cohort was divided into two groups (MRI Cohort 1 and 
2) according to the scanner upgrade status, and this variable was in-
cluded in the statistical tests as a covariate.  
An automatic image analysis workflow was utilized to measure total 
and regional brain volumes in each neonate. First, T2-weighted ana-
tomical images were re-sampled to a super-resolution image using the 
principles described in previous reports 21. Non-brain tissue parts of 
the axial, coronal and sagittal T2-weighted images were removed by 
applying image masks generated from an age-specific neonatal neuro-
anatomical atlas. The masked, axial and coronal images were co-
registered to the sagittal image using a mutual information based af-
fine and non-linear registration as implemented in the Niftireg image 
registration package 22. A slice-wise reconstruction step, which is usu-
ally employed during super-resolution reconstructions 23, was skipped 
due to the relative scarcity of subject motion, and since any motion-
corrupted scans had been repeated. Bias field correction of the images 
was performed by the N4ITK filter in the Slicer 3D software 24, while 
further steps of the re-sampling were carried out using the BTK Toolkit 
25. The original, three-plane T2 images and the 3DT2 reconstruction 
are illustrated in Figure 1/a. 
 
Figure 1. 3D reconstruction and brain segmentation. a. reconstruction of 3D 
T2-weighted images (bottom row) from three orthogonally acquired images, 
b. example segmentations: cortex, white matter and cerebellum (top row), 
and four-lobe segmentation (bottom row). 
Anatomical priors from the gestational age-specific neonatal anatom-
ical atlas ALBERTs 26 were matched to the subjects reconstructed 
images using a freeform non-linear deformation (reg_f3d command in 
the Niftireg software) with a fine transformation grid of 8 x 8 x 8 mm, 
penalty term was bending energy with a setting of 0.0035 to allow for 
more accurate alignment between the template and subject’s images. 
The anatomical masks of white matter, grey matter (cortex only) and 
lobar subdivisions of the supratentorial white matter (frontal, parietal, 
temporal and occipital lobe) and cerebellum were matched to the T2-
weighted super-resolution images. Total brain (parenchymal) volume 
was estimated by constructing a whole-brain mask, which included the 
diencephalon, cortical mantle, supratentorial white matter, but not 
the intra- and extra axial cerebrospinal fluid spaces or cerebellum. The 
patient-specific priors 27 were thresholded at 50 % probability, and 
their volume was stored for the statistical evaluations (example seg-
mentations: Figure 1/b). 
To validate the automated atlas-based volumetry workflow against 
manual volumetry, a stereological analysis of a sub-set of the study 
sample was performed. Stereology was carried out using the 
EasyMeasure software package 28, following a method that has previ-
ously been described in detail elsewhere 29. The validation showed 
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good agreement between the two methods, with a Pearson correla-
tion coefficient ranging from 0.930 (p < 0.01) for the total brain 
volume and 0.827 (p < 0.01) for the cerebellar volume. In-depth de-
tails and results of the validation process are given in the 
Supplementary Information. 
Following this initial validation, all subsequent analyses including brain 
volumes were performed by the automated pipeline.  
Brain growth was defined as the weekly rate of volumetric change of 
the brain and its major subdivisions, calculated by using the volumetric 
measurements of the pre- and postoperatively acquired MRI scans.  
Statistical analyses. All analyses were conducted using the statistical 
software R, Version 3.5.0 30. Results were considered to be significant 
at a p-level of < 0.05. Subject demographics are listed in table 1 as 
mean and standard deviation (SD) for normally distributed continuous 
variables and median and interquartile range (IQR) for non-normally 
distributed continuous variables. Categorical variables are reported as 
proportions. Groupwise comparisons for continuous variables were 
performed by t tests and Man-Whitney U tests as appropriate for the 
sample distributions and comparisons for categorical variables were 
assessed using Fisher´s exact test. To quantify the associations be-
tween brain volumes and neurodevelopmental outcome we 
calculated a series of multiple linear regression models adjusted for 
postmenstrual age at MRI, SES, sex and MRI cohort, with the latter ac-
counting for a software update on the scanner during the time of the 
study. To further correct for possible confounds associated with the 
length of ICU stay, this variable was consecutively introduced into the 
model. Square root transformation for dependent variables such as 
brain volumes and Bayley-III composite scores was performed to meet 
the assumptions of multiple linear regression models. Pearson corre-
lation coefficients were calculated to determine the relationship 
between potential risk factors and total brain volumes in infants with 
CHD.  
Results  
Study population. In this prospective cohort study, 77 infants with a 
severe CHD were enrolled between December 2009 and August 2016 
and 44 healthy infants were recruited as controls. In the CHD group, 
70 had a preoperative MRI, 68 had a postoperative MRI and 60 had 
both a pre-and postoperative MRI. Reasons for missing preoperative 
brain MRI included patient instability and too short of a time period 
between recruitment and surgery (n = 7). In addition, 3 scans could 
not be included in the regional volumetric analyses due to motion ar-
tefacts. Postoperatively, 10 patients did not have a cerebral MRI 
because infants were too old to undergo MRI in natural sleep (n = 6), 
or for logistical reasons. Furthermore, 6 postoperative scans could not 
be analysed due to poor image quality (see Supplementary Fig. S1). 
Among the MRIs of healthy controls, one could not be analysed due to 
motion artefacts. Hence, volumetric analysis was performed for 67 
CHD infants preoperatively, 62 postoperatively and for 43 controls. 
Mean (± SD) time between pre-and postoperative MRI scans in CHD 
infants was 20 (± 8) days. 
Table 1. Characteristics of infants with CHD and healthy controls. M 
= Median, m = mean, IQR = interquartile range, SD = standard devia-
tion. CHD, congenital heart disease; GA, gestational age; ICU, intensive 
care unit; SES, socioeconomic status; PMA, postmenstrual age; MRI, 
magnetic resonance imaging; NA, not applicable. Groupwise compari-
son for categorical variables was performed by Fisher´s exact test and 
for continuous variables t test and Man-Whitney U test were applied 
appropriate for sample distribution. 
 
Infants with 
CHD 
Controls p 
n 77 44  
Male, n (%) 58 (75.3) 20 (45.5) 0.002 
Birthweight, g (m (SD)) 3347.7 (491.5) 3432.0 (402.5) 0.34 
GA, wks (m (SD)) 39.4 (1.3) 39.6 (1.2) 0.42 
Head circumference at 
birth, cm (m (SD)) 
34.6 (1.3) 35.1 (1.2) 0.035 
Apgar 5 (M [IQR]) 9.0 [8.0, 9.0] 9.0 [9.0, 9.0] 0.29 
SES (2-12) (M [IQR]) 8.0 [7.0, 10.0] 
12.0 [10.0, 
12.0] 
<0.001 
Cyanotic vitium, n (%) 69 (89.6) NA  
Highest lactate preoper-
atively, mmol/l (M 
[IQR]) 
4.3 [3.1, 6.1] NA  
Age at surgery, d (M 
[IQR]) 
12.0 [9.0, 16.0] NA  
Extracorporeal circula-
tion time, min (m (SD)) 
153.1 (78.0) NA  
Aortic cross clamp time, 
min (m (SD)) 
93.4 (52.7) NA  
Lowest temperature on 
bypass, °C (M [IQR]) 
28.1 [23.1, 31.5] NA  
Days on ICU postopera-
tively (m (SD)) 
7.9 (10.1) NA  
Age, days (M [IQR]) at    
Preoperative MRI 7.0 [5.2, 8.8] 
21.0 [16.0, 
28.0] 
 
Postoperative MRI 25.0 [20.8, 31.0]   
PMA, weeks (M [IQR]) 
at 
   
Preoperative MRI 40.2 [39.3, 41.2] 42.3 [41.2, 
43.6] 
 
Postoperative MRI 43.2 [41.4, 44.1]  
Table 1 presents demographic characteristics of the CHD infants and 
controls. Complete data (pre- and postoperative analysed brain scans 
and Bayley-III assessment) were collected for a total of 50 CHD infants. 
Details on CHD diagnoses are listed in Table 2.  
Cerebral MRI: pre- and postoperative brain injury. On the preopera-
tively acquired MRI scans, 14 out of 67 (20.9 %) patients had a brain 
lesion, comprised of either white matter injury (WMI) and/or stroke. 
WMI was detected in 14 (19.7 %) (11 minimal, 2 moderate and 1 se-
vere injury), and stroke was detected in 4 (8.5 %) infants (1 anterior 
cerebral artery, 2 middle cerebral artery, 1 posterior cerebral artery). 
Two infants had both WMI and stroke. On the postoperative MRI new 
postoperative lesions were found in 2 of the 68 scanned infants (2.9 %) 
and all were minimal white matter injuries. In 13 of the 16 infants with 
preoperative stroke and/or WMI, lesions persisted to postoperative 
scans (81.3 %).  
Cerebral MRI: volumetric findings. We report three main findings re-
garding the differences in cerebral volumes between CHD infants and 
controls.  
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Table 2. Distribution of cardiac diagnoses of infants with CHD. CHD, congenital 
heart disease; dTGA, dextro-transposition of the great arteries; DORV, double 
outlet right ventricle, HLHS, hypoplastic left heart syndrome; HLHC, hypoplastic 
left heart complex. 
Cardiac diagnosis n 
Biventricular  62 
dTGA 38 
Aortic arch anomaly 8 
DORV TGA type 7 
Other† 9 
Univentricular 15 
HLHS/HLHC 9 
Other* 6 
† Other biventricular diagnoses include neonates with atrioventricular septal de-
fect (n = 2), ventricular septal defect (n = 1), pulmonary atresia with ventricular 
septal defect (n = 4), tetralogy of Fallot (n = 1) and levo-transposition of the 
great arteries (n = 1).  
* Other univentricular diagnoses (non HLHS/HLHC) include neonates with tri-
cuspid atresia (n = 3), pulmonary atresia with intact ventricular septum (n = 1), 
double inlet left ventricle (n = 1) and heterotaxy syndrome (n = 1). 
Table 3. Pre- and postoperatively measured absolute brain volumes of CHD 
infants and controls in cm3 given as mean (standard deviation). P-values and 
ß coefficients (ß) based on multiple linear regression analyses adjusted for sex, 
postmenstrual age at MRI, MRI cohort.  
 Brain Volume  Group comparison 
 Preop 
n = 67 
Postop 
n = 62 
Con-
trols 
n = 43 
 Preop 
vs. Con-
trols, ß 
Postop 
vs. Con-
trols, ß 
Total brain 371.3 
(51.5) 
395.2 
(40.8) 
434.7 
(51.6) 
 -1.21† -1.43† 
Cortex 253.8 
(43.5) 
273.8 
(33.7) 
302.5 
(39.4) 
 -1.06† -1.29† 
White mat-
ter 
189.4 
(26.7) 
196.2 
(20.7) 
216.6 
(26) 
 -0.81† -0.97† 
Frontal lobe 105.7 
(13.4) 
111.5 
(11.3) 
124.3 
(14.9) 
 -0.72† -0.82† 
Parietal lobe 69.8 
(11.3) 
73.1 
(8.6) 
80.4 
(11.8) 
 -0.45** -0.59† 
Occipital 
lobe 
33.1 
(6.9) 
35.7 
(4.1) 
39.6 
(4.7) 
 -0.43** -0.44† 
Temporal 
lobe 
62.8 
(8.8) 
66.6 
(7.2) 
72.2 
(8.8) 
 -0.46† -0.51† 
Cerebellum 31.1 
(5.8) 
33.9 
(4.7) 
37.7 
(5.9) 
 -0.36** -0.46† 
P-values coded as: ** = p < 0.001, † = p < 0.0001. Preop, preoperative; Postop, 
postoperative. 
First, CHD infants had lower total and regional brain volumes in all re-
gions pre- and postoperatively without a specific regional predilection 
(Table 3). When comparing relative regional brain volumes (corrected 
for total brain volume) of CHD infants with controls we found the pre-
operative relative frontal lobe to be smaller in the CHD group (ß = -
0.18 95 % CI -0.32 to -0.04, p = 0.012), whereas the preoperative rela-
tive parietal lobe appeared to be larger (ß = 0.12, 95 % CI 0.01 to 0.23, 
p = 0.035). For postoperative relative regional brain volumes, no dif-
ference was found. Second, CHD infants with a preoperative lesion 
had significantly smaller cerebellar volumes on the preoperative MRI 
(28.14 cm3 vs. 31.85 cm3, 95 % CI -7.07 to -0.35, p = 0.031), but not on 
the postoperative MRI (32.24 cm3 vs. 34.7 cm3, 95 % CI -5.38 to 0.45, 
p = 0.095). There was no significant difference in total brain volume 
(neither pre-, nor postoperative) or in other regional brain volumes 
between patients with and without preoperative brain lesions. Third, 
total brain volume was found to be smaller in female compared to 
male CHD infants (preoperative: mean 347.27 cm3 vs. 379.53 cm3 
(95 % CI 4.26 to 60.25, p = 0.025); postoperative: 369.12 cm3 vs. 
404.29 cm3 (95% CI 13.05 to 57.28, p = 0.002). In contrast, there was 
no difference in total brain volume between male and female controls 
(95 % CI -50.13 to 13.35, p = 0.249).  
Preoperative and postoperative total brain volumes correlated with 
head circumference at birth (preoperative: r = 0.43, 95 % CI 0.20 to 
0.62, p = 0.0005; postoperative: r = 0.65, 95 % CI 0.46 to 0.78, 
p < 0.0001), gestational age (preoperative: r = 0.29, 95 % CI 0.05 to 
0.5, p = 0.019; postoperative: r = 0.3, 95 % CI 0.05 to 0.5, p = 0.018) 
and birth weight (preoperative: r = 0.47, 95 % CI 0.25 to 0.63, 
p < 0.0001, postoperative: r = 0.57, 95 % CI 0.37 to 0.71, p < 0.0001). 
Furthermore, we investigated the impact of perinatal and intraopera-
tive variables (i. e. 5 min Apgar score, extracorporeal circulation time, 
lowest temperature on bypass, aortic cross clamp time) on postoper-
ative total brain volumes and found no significant correlation (see 
Supplementary Table S1 online). However, a longer length of ICU stay 
was associated with smaller postoperative total brain volume (r = -
0.25, 95 % CI -0.48 to -0.00, p = 0.047). Group comparison further re-
vealed no difference in postoperative whole brain volume for infants 
with or without dTGA (mean 393.38 cm3 vs. 396.63 cm3, 95 % CI -24.33 
to 17.83, p = 0.53) or univentricular heart defect (396.47 cm3 vs. 
388.66 cm3, 95 % CI -20.56 to 36.19, p = 0.76).  
Neurodevelopmental outcome at one year. Neurodevelopmental as-
sessments were performed at a median [IQR] age of 12.0 months 
[12.0, 13.0] for CHD infants and 12.0 months [12.0, 12.0] for controls. 
One infant died prior to the one-year examination and 2 of 76 surviv-
ing CHD infants did not return for the neurodevelopmental 
assessment (follow up rate 97.4 %). In two infants, the language score 
could not be assessed due to non-German language. Among the 44 
control children 7 were lost to follow up (follow up rate 84.1 %). The 
Bayley-III CCS and MCS scores were significantly lower in CHD patients 
than in controls: CCS (mean (SD)) 105 (15.3) vs. 117.1 (11.3), (95% CI 
6.43 to 17.68, p<0.0001); MCS 92.7 (15.4) vs. 103.8 (10.9), (95 % CI 
5.50 to 16.74, p = 0.0002). For the LCS only a trend towards lower 
scores in CHD patients was found: 92.7 (14.0) vs. 97.5 (9.9), (95 % CI -
0.30 to 9.96, p = 0.06). After adjustment for SES, the differences in CCS 
(ß = -0.34, 95 % CI -0.66 to -0.02, p = 0.037) and MCS (ß = -0.37, 95 % 
CI -0.72 to -0.03, p = 0.036) among infants with CHD compared to con-
trols remained, while no association was found for the LCS (ß = -0.06, 
95 % CI -0.37 to 0.25, p = 0.70). Multiple linear regression, adjusted for 
SES revealed that MCS was higher for CHD patients with dTGA com-
pared to patients with non-dTGA diagnoses (ß = 0.50, 95 % CI 0.13 to 
0.88, p = 0.009), while CCS and LCS was not (CCS ß = 0.23, 95 % CI -0.12 
to 0.58, p = 0.19; LCS ß = -0.24, 95 % CI -0.58 to 0.09, p = 0.15). Length 
of ICU stay was negatively associated with CCS (ß = -0.018, 95 % CI -
0.04 to -0.00, p = 0.045) and MCS (ß = -0.02, 95 % CI -0.04 to -0.00, 
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p = 0.036), but not with LCS (ß = -0.003, 95 % CI -0.02 to 0.01, 
p = 0.73).  
Brain growth. All postoperative brain volumes in infants with CHD 
were significantly larger than preoperative brain volumes (see Supple-
mentary Table S2 online). We furthermore evaluated whether the 
brain growth rate was lower in CHD infants than the estimated growth 
from the cross-sectionally acquired growth in the healthy controls. The 
estimated weekly growth of the total brain volume of controls, esti-
mated by fitting a linear function to the cross sectional volumetric data 
of controls, exceeded that of the CHD infants (controls 22.3 cm3 per 
week, CHD 11.0 cm3 per week). The estimated cerebral growth rate in 
controls exceeded the observed growth rate of 91.4 % of the CHD in-
fants (Figure 2, Supplementary Figure S4, Supplementary Figure S5).  
Relationship between perioperative cerebral MRI findings with neu-
rodevelopmental outcome. Cerebral lesions on pre- and post-
operative MRI did not predict neurodevelopmental outcome. Preoper-
ative brain volumes in CHD infants (including those from the total 
brain, cortex, white matter, frontal-, parietal- and temporal lobes and 
cerebellum) were not associated with one-year neurodevelopmental 
outcome when corrected for sex, postmenstrual age at time of MRI, 
MRI cohort and SES (see Supplementary Table S3 online). Similarly, no 
association was found between neonatal brain volume and one-year 
outcome in healthy controls (see Supplementary Table S4 online).  
 
Figure 2. Growth trajectories of total brain volumes of CHD infants compared 
to controls. Red dots: brain volume of controls, Red line: cross-sectional brain 
growth of the controls. Black circles: preoperative brain volume of the CHD in-
fants. Black dots filled: postoperative brain volume of the CHD infants. Black 
line: brain growth of CHD infants. 
In contrast, postoperative regional brain volumes were associated 
with the one-year neurodevelopmental outcome. Specifically, the to-
tal brain, cortical, white matter, frontal lobe, temporal lobe and 
cerebellar volumes were positively associated with CCS. Furthermore, 
total brain, cortical, frontal lobe and temporal lobe volumes were as-
sociated with LCS (Table 4), when adjusted for sex, postmenstrual age 
at time of MRI, MRI cohort and SES. When additionally introducing 
length of ICU stay into the multiple regression model, CCS remained 
significantly associated with frontal (ß = 0.02, 95 % CI 0.00 to 0.04, 
p = 0.043), temporal (ß = 0.039, 95 % CI 0.01 to 0.07, p = 0.014) and 
cerebellar (ß = 0.056, 95 % CI 0.01 to 0.10, p = 0.018) volumes, 
whereas LCS remained independently predicted by cortical 
(ß = 0.0079, 95 % CI 0.00 to 0.02, p = 0.045), temporal (ß = 0.032, 
95 % CI 0.00 to 0.06, p = 0.046) and frontal (ß = 0.021, 95 % CI 0.00 to 
0.04, p = 0.027) brain volumes. In contrast, relative regional volumes 
(adjusted for total brain volume) did not correlate with neurodevelop-
mental outcome either in the pre- or in the postoperative MRI in CHD 
infants and in controls. In addition, neither total brain growth nor re-
gional brain growth was predictive of any of the Bayley-III scores (see 
Supplementary Table S5 online).  
Table 4. Multiple linear regression models for each respective regional brain 
volume and neurodevelopmental outcome domain. The model was adjusted 
for the covariates sex, postmenstrual age at MRI, MRI cohort and socioeco-
nomic status. CCS, Bayley-III Cognitive Composite Score; LCS, Bayley-III 
Language Composite Score; TBV, total brain volume; CI, Confidence Interval. 
Only significant associations are shown. Further details on the model and non-
significant results can be found in the Supplementary Table S6 online. 
Dependent 
variable 
Independent 
variable* 
ß Co-
efficie
nt 
95 % CI p 
CCS TBV 0.0065 0.00 to 0.01 0.037 
CCS Cortex 0.0092 0.00 to 0.02 0.027 
CCS WM 0.012 0.00 to 0.02 0.036 
CCS Frontal lobe 0.022 0.00 to 0.04 0.027 
CCS Temporal 0.044 0.01 to 0.08 0.008 
CCS Cerebellum 0.06 0.01 to 0.11 0.017 
LCS TBV 0.0061 0.00 to 0.01 0.037 
LCS Cortex 0.0084 0.00 to 0.02 0.031 
LCS Frontal lobe 0.022 0.00 to 0.04 0.02 
LCS 
Temporal 
lobe 
0.033 0.00 to 0.06 0.035 
Discussion 
In this prospective cohort study, we examined the association be-
tween perioperative brain volumes and one-year 
neurodevelopmental outcome in children with severe CHD undergo-
ing CPB. In our cohort, CHD infants had smaller global and regional 
brain volumes pre- and postoperatively. To the best of our knowledge, 
we are the first to show that postoperative total brain volume as well 
as cortical, frontal, temporal, white matter and cerebellar volume 
were predictive of neurodevelopmental outcome at one year, while, 
in contrast, preoperative brain volumes were not predictive of out-
come. WMI was the predominant preoperative cerebral injury, 
whereas strokes and new postoperative lesions were rare. Im-
portantly, both pre- and postoperative lesions were not predictive of 
neurodevelopmental outcome.  
We found that brain volumes were smaller pre- and postopera-
tively in infants with CHD, and that all regional volumes were affected 
without a regional predilection. This is in line with the finding that the 
majority of relative regional brain volumes (after correcting for total 
brain volume) where similar between CHD infants and controls. These 
results are in accordance with those by von Rhein et al. 3 and Ortinau 
et al. 8, and most likely reflect a general developmental disturbance of 
brain growth and connectivity of foetal origin 31. Studies on older chil-
dren with CHD showed that brain volume reduction persists for all 
types of CHD from early childhood 32-34 until adolescence 35 and corre-
lates with functional outcome. Importantly, we could not detect a 
predilection for a white or grey matter volume reduction. Watanabe 
et al. demonstrated a volume reduction that was most prominent in 
the grey matter, in particular in the frontal region, in children with CHD 
aged 13-15 months. In contrast, Rollins et al. found a reduction in 
white matter volume and a correlation with language function but not 
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with cognitive or motor development at one year of age. However, in 
this study cerebral MRI was assessed at one year of age and alterations 
in brain growth may have become more apparent 33. A study by Owen 
et al. demonstrated that the subcortical grey matter was reduced and 
the cerebrospinal fluid was increased in a mixed group of CHD infants 
and that these volume changes correlated with poor behavioural state 
regulation and poor visual orienting on the neonatal examination 4. 
The difference in regional predilection may be due to differences in 
the distribution of studied cardiac diagnoses and medical variables 
such as postoperative course and complications.  
We demonstrated that total postoperative brain volume and cer-
tain regional volumes were predictive of one-year cognitive and 
language outcome. Relative regional brain volumes, that is after con-
trolling for total brain volume, however, did not correlate with 
outcome, as would be expected given the lack of a predilection for a 
certain brain region in the volume reduction.  
While little is known about the association between neonatal 
brain volumes and outcome for the CHD populations, this association 
is well established for other at–risk populations. In children with peri-
natal asphyxia, hippocampal volume has been found to be reduced 
and associated with long-term outcome such as cognitive memory im-
pairment as reviewed by de Haan et al. 36. In preterm born infants, 
there is mounting evidence for a reduction in total and regional brain 
volumes with predictive value for neurodevelopmental outcome, 
which is particularly strong for the cerebellar volume 37-39. However, in 
healthy infants in which no alteration or interruption of brain devel-
opment occurs, the association between brain volume and outcome 
cannot be found.  
We further examined potential risk factors for reduced pre- and 
postoperative brain volumes. While we found that neonatal charac-
teristics such as head circumference at birth, gestational age and birth 
weight were related to pre- and postoperative total brain volume, 
longer length of postoperative ICU stay was related to lower postop-
erative brain volume. We assume that ICU stay is an indicator of 
disease complexity and is thus a strong factor influencing brain growth 
and by that neurodevelopmental outcome. However, in addition to 
this association, we found that, after adjusting for ICU stay, frontal, 
temporal and cerebellar brain volumes were independent predictors 
of cognitive outcome, and cortical frontal and temporal volumes of 
language outcome. These findings suggest that brain volume reduc-
tion is not just a mere mediator of the impact of ICU stay on outcome, 
but is also independently associated with outcome.  
Our findings are consistent with those of Rollins et al., who exam-
ined CHD children at one year of age and found an association 
between a longer ICU stay and reduced grey matter volume as well as 
between lower intraoperative pCO2 and reduced total brain volume. 
No other risk factor for lower brain volume was identified in their 
study 33. Interestingly, no other, and in particular no surgical or cardiac 
variable (i. e. extracorporeal circulation time, lowest temperature on 
bypass, aortic cross clamp time, univentricular CHD, dTGA vs. non-
dTGA) was related to postoperative total brain volume. This observa-
tion is in line with the results from a large cohort of CHD infants in 
which measured intraoperative and postoperative factors accounted 
for less than 5% of the variances in one-year outcome while patient-
specific and preoperative factors contributed much more to outcome. 
40.  
Our study confirms that the predominant injuries in CHD infants 
are WMI and strokes, and new postoperative lesions are rare 2,11,41. 
However, the prevalence of cerebral lesions may vary significantly de-
pending on the type of CHD studied 9,18,41. Consistent with the findings 
of Beca et al. 11, the cerebral lesions in our cohort were small, and 
therefore may lack an association with neurodevelopmental outcome, 
whereas others demonstrated a correlation between perioperative 
brain injuries and early childhood outcome 12,18,19. This indicates that 
the presence or absence of an association between brain lesions and 
outcome depends on the distribution of CHD diagnoses, the rate of 
lesions and the method of quantification. While the presence or ab-
sence of lesions may not be useful in predicting outcome, the volume 
of white matter injury may better reflect the burden of injury and by 
that may be predictive of outcome as has been recently demonstrated 
by Peyvandi et al. 12.  
Neurodevelopmental outcome in the CHD population was lower 
in all domains but within the normal range. Our outcomes are in line 
with the findings of Andropoulos et al. who also used the Bayley-III in 
their cohort 18, although earlier. However, the test version needs to be 
considered when comparing outcome results among studies. It has 
been shown that the Bayley-III generates significantly higher scores 
compared to the Bayley-II, and thus overestimates functional outcome 
42.  
Brain growth between pre- and postoperative scans was reduced 
in CHD infants, but not predictive of outcome. Brain volume appears 
to increase in healthy infants at a higher rate than in CHD patients in 
their first weeks of life. This observation may be linked to the persist-
ing developmental impairment of the central nervous system even 
after corrective surgery. We hypothesize that a stronger association 
between early brain growth rate and outcome would be found if a 
longer period was examined, as has been shown in the population of 
preterm born infants by Cheong et al. 43. They could demonstrate that 
a poor postnatal head growth, as a surrogate marker for brain growth, 
became evident between birth and two years of age and was predic-
tive of neurodevelopmental outcome 43.  
We suggest that a multiple-hit-theory could explain why the pre-
operatively measured brain volumes did not correlate with outcome, 
whereas the postoperative volumes did. In this model, the “first hit” 
takes place during prenatal life, caused by different factors such as hy-
poperfusion and neuronal disturbances, while the second hit occurs 
during the perioperative phase. The additive or potentiating effect of 
these events may only become evident during later development, and 
the inter-individual variability of brain growth trajectories will become 
larger in later life. A more precise assessment of a possible divergence 
in such growth trajectories would necessitate longitudinal neurodevel-
opmental evaluations and repeated MR imaging with volumetry over 
multiple months after surgery. 
This study has several strengths. Pre- and postoperative MRIs 
could be obtained in a large number of patients and brain volumes 
were measured with an automated pipeline in a fast and reliable fash-
ion. The follow up rate of one-year neurodevelopmental follow up was 
excellent and assessment was performed with a detailed, standard-
ized developmental test (Bayley-III). However, there are also 
considerable limitations. It is important to note that the predictive 
value of the Bayley-III assessment for long-term neurodevelopmental 
outcome is limited 44. Later neurodevelopmental follow up is war-
ranted to confirm our results. Subgroup analyses or stratification of 
the linear regression results by the CHD diagnoses would yield more 
specific results, but power to detect differences is limited due to sam-
ple size. Moreover, our study population is a heterogeneous, clinically 
diverse sample composed of patients with various CHD diagnoses. Fur-
thermore, we performed multiple regression analyses to investigate 
the predictive effect of regional brain volumes, leading to multiple hy-
pothesis tests which must be considered when interpreting the results 
as we did not correct for multiple testing. A technical limitation of our 
study is that the MRI scanner was upgraded during the study. While 
the same pulse sequence was used, the upgrade could theoretically 
affect the MRI contrast, potentially introducing a bias into the brain 
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volumes calculated using the automated approach. To control for the 
confounding effect of MRI scanner software type, we corrected for 
this variable in all statistical analyses, and we additionally validated 
the volumes derived using the automated approach with those from a 
manual gold-standard method. However, the in-house developed au-
tomatic work-flow should also be compared to alternative automated 
approaches in the future 29. During the validation of the anatomical 
prior based automatic segmentation approach (Supplementary Note), 
we found high variability for total cortical volume, which limits the 
generalisability of our volumetric findings. More reliable and repro-
ducible results can be expected for lobar white matter, total brain 
volume and cerebellar volume estimates, which was confirmed by 
higher correlation and spatial overlap of these volume estimates with 
a more recently published automated approach (dHCP pipeline, more 
details are found in Supplementary Note), and higher correlation to 
manual stereology. 
In sum, we found that postoperative regional brain volumes of 
children with CHD were smaller than those of controls and were pre-
dictive of neurodevelopmental outcome while preoperative brain 
volumes were not. Our findings add to the evidence of an association 
between neonatal brain volumes and neurodevelopmental outcome 
across at-risk populations. Our results underscore the importance of 
early neuroimaging assessments in infants with severe CHD, providing 
measures such as the total brain volume which could serve as a bi-
omarker for altered brain development in combination with a more 
complicated postoperative course.  
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Supplementary Figure S1. Flowchart of enrolled CHD infants. CHD, congenital 
heart disease; postop, postoperative; preop, preoperative; MRI, magnetic resonance 
imaging, Bayley-III, Bayley Scales of Infant and Toddler Development, Third Edition. 
 
 
 
 
 
 
 
 
 
 
  
77 CHD infants
70 CHD infants with preop MRI                                                                                       68 CHD infants with postop MRI
50 complete cases with
preop­ and postop MRI  
and Bayley­III
10 missing postop MRI7 missing preop MRI
67 preop volumetric
analysis
64 preop MRI and
Bayley­III
3 motion artefacts
3 lost to follow up
62 postop volumetric
analysis
60 postop MRI and
Bayley­III
6 motion artefacts
2 lost to follow up
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Supplementary Table S1. Correlation between perinatal and intraoperative risk 
factors and postoperative total brain volume. Pearson correlation of risk factors 
and postoperative total brain volume. r, correlation coefficient; CI, confidence interval; 
ECC, extracorporeal circulation time; ACC, aortic cross clamp time.  
 
Risk factor r 95 % CI p 
Apgar 5 min -0.017 -0.26; 0.23 0.90 
ECC 0.072 -0.19; 0.32 0.58 
Lowest temperature on bypass 0.14 -0.13; 0.38 0.32 
ACC 0.079 -0.18; 0.32 0.55 
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Supplementary Table S2. Comparison of pre- and postoperative brain volumes 
in CHD infants. Paired t test. CI, confidence interval. 
 
Brain volume 
Mean difference  
(cm3) 
95 % CI p 
Total brain volume 30.49 18.42; 42.56 < 0.0001 
Cortex 25.97 15.91; 36.03 < 0.0001 
White matter 10.45 4.29; 16.60 0.0013 
Frontal lobe 7.67 4.36; 10.98 < 0.0001 
Parietal lobe 4.55 2.16; 6.94 0.0003 
Occipital lobe 3.61 1.87; 5.35 0.0001 
Temporal lobe 5.10 3.28; 6.93 < 0.0001 
Cerebellum 3.94 2.74; 5.14 < 0.0001 
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Supplementary Table S3. Association between preoperative neonatal brain 
volume and one-year neurodevelopmental outcome in CHD infants. Multiple linear 
regression models for each respective preoperative brain volume and 
neurodevelopmental outcome domain in CHD infants. ß, ß coefficient of the covariates; 
CI, confidence interval; Adj, adjusted; TBV, total brain volume; PMA, postmenstrual 
age; MRI, magnetic resonance imaging; SES, socioeconomic status. p Model 
corresponds to p-value of the linear regression model. 
 
Cognitive Composite Score Language Composite Score Motor Composite Score 
 ß 95 % CI p ß 95 % CI p ß 95 % CI p 
Intercept 9,52  5.60 ; 13.44 < 0.0001 8,34  4.61 ; 12.06 < 0.0001 7,3  2.99 ; 11.62 0.001 
TBV 0,0038  -0.00 ; 0.01 0,13 0,0032  -0.00 ; 0.01 0,17 0,00068  -0.00 ; 0.01 0,8 
Sex -0,33  -0.77 ; 0.11 0,14 -0,23  -0.65 ; 0.18 0,27 -0,11  -0.59 ; 0.38 0,66 
PMA at MRI -0.028  -0.12 ; 0.06 0,53 -0.016  -0.10 ; 0.07 0,71 0.031  -0.07 ; 0.13 0,53 
MRI Cohort 0,2  -0.18 ; 0.58 0,29 0,24  -0.12 ; 0.60 0,19 0,41  -0.01 ; 0.83 0.055 
SES 0.091  0.00 ; 0.18 0.045 0,1  0.02 ; 0.18 0,02 0.068  -0.03 ; 0.17 0,17 
 Adj R2: 0.073 Adj R2: 0.091 Adj R2: 0.027  
 p Model: 0.12 p Model: 0.081 p Model: 0.28 
Intercept 10,1  6.27 ; 13.94 < 0.0001 8,84  5.18 ; 12.49 < 0.0001 7,43  3.15 ; 11.72 0.001 
Cortex 0,0063  0.00 ; 0.01 0.047 0,0054  -0.00 ; 0.01 0.073 0,0018  -0.01 ; 0.01 0,61 
Sex -0,38  -0.81 ; 0.06 0.089 -0,27  -0.69 ; 0.14 0,19 -0,13  -0.62 ; 0.36 0,6 
PMA at MRI -0.044  -0.14 ; 0.05 0,34 -0,03  -0.12 ; 0.06 0,5 0.025  -0.08 ; 0.13 0,63 
MRI Cohort 0,1  -0.29 ; 0.49 0,6 0,15  -0.22 ; 0.53 0,41 0,38  -0.06 ; 0.81 0.088 
SES 0.092  0.00 ; 0.18 0.039 0,1  0.02 ; 0.18 0.017 0.068  -0.03 ; 0.16 0,17 
 Adj R2: 0.10 Adj R2: 0.12 Adj R2: 0.031  
 p Model: 0.061 p Model: 0.047 p Model: 0.26 
Intercept 9,18  5.12 ; 13.25 < 0.0001 8,05  4.19 ; 11.91 0,0001 7,45  3.01 ; 11.89 0.001 
White matter 0.006  -0.00 ; 0.02 0,21 0,0051  -0.00 ; 0.01 0,25 -0,00072  -0.01 ; 0.01 0,89 
Sex -0,3  -0.74 ; 0.13 0,17 -0,21  -0.62 ; 0.20 0,31 -0.082  -0.56 ; 0.40 0,73 
PMA at MRI -0.016  -0.10 ; 0.07 0,71 -0,0055  -0.09 ; 0.08 0,9 0.036  -0.06 ; 0.13 0,45 
MRI Cohort 0,29  -0.11 ; 0.68 0,15 0,31  -0.06 ; 0.69 0,1 0,4  -0.03 ; 0.84 0.065 
SES 0.091  0.00 ; 0.18 0.046 0,1  0.02 ; 0.19 0.021 0,07  -0.03 ; 0.17 0,16 
 Adj R2: 0.061 Adj R2: 0.080 Adj R2: 0.026 
 p Model: 0.15 p Model: 0.10 p Model: 0.28 
Intercept 9,49  5.56 ; 13.42 < 0.0001 8,24  4.54 ; 11.94 < 0.0001 7,44  3.12 ; 11.76 0.001 
Frontal lobe 0.014  -0.00 ; 0.03 0,14 0.014  -0.00 ; 0.03 0,1 -0,0028  -0.02 ; 0.02 0,79 
Sex -0,34  -0.79 ; 0.10 0,13 -0,26  -0.68 ; 0.16 0,22 -0.069  -0.56 ; 0.42 0,78 
PMA at MRI -0.029  -0.12 ; 0.06 0,52 -0.021  -0.11 ; 0.06 0,63 0,04  -0.06 ; 0.14 0,43 
MRI Cohort 0,25  -0.13 ; 0.63 0,19 0,29  -0.07 ; 0.65 0,11 0,41  -0.01 ; 0.83 0.056 
SES 0.089  -0.00 ; 0.18 0.051 0.097  0.01 ; 0.18 0.024 0.071  -0.03 ; 0.17 0,15 
 Adj R2: 0.071  Adj R2: 0.10  Adj R2: 0.027 
 p Model: 0.12 p Model: 0.060 p Model: 0.27 
Intercept 9,3  5.43 ; 13.17 < 0.0001 8,39  4.61 ; 12.17 < 0.0001 7,15  2.84 ; 11.46 0.002 
Parietal lobe 0.022  0.00 ; 0.04 0.046 0,0095  -0.01 ; 0.03 0,38 0,0086  -0.02 ; 0.03 0,48 
Sex -0,33  -0.75 ; 0.09 0,12 -0,19  -0.61 ; 0.22 0,35 -0,12  -0.60 ; 0.35 0,6 
PMA at MRI -0.028  -0.12 ; 0.06 0,52 -0.007  -0.09 ; 0.08 0,87 0.027  -0.07 ; 0.12 0,57 
MRI Cohort 0,29  -0.09 ; 0.67 0,13 0,29  -0.08 ; 0.65 0,13 0,44  0.02 ; 0.86 0.042 
SES 0.093  0.01 ; 0.18 0.037 0,1  0.02 ; 0.19 0.018 0.068  -0.03 ; 0.16 0,17 
 Adj R2: 0.10  Adj R2: 0.071 Adj R2: 0.036 
 p Model: 0.06 p Model: 0.12 p Model: 0.24 
Intercept 9,78  5.78 ; 13.77 < 0.0001 8,48  4.72 ; 12.25 < 0.0001 7,37  3.07 ; 11.68 0.001 
Occipital lobe 0,0078  -0.03 ; 0.04 0,66 0.014  -0.02 ; 0.05 0,41 -0,00057  -0.04 ; 0.04 0,98 
Sex -0,26  -0.70 ; 0.18 0,24 -0,18  -0.60 ; 0.23 0,37 -0.088  -0.56 ; 0.38 0,71 
PMA at MRI -0.011  -0.10 ; 0.08 0,81 -0,0038  -0.09 ; 0.08 0,93 0.035  -0.06 ; 0.13 0,46 
MRI Cohort 0,21  -0.18 ; 0.60 0,28 0,24  -0.13 ; 0.60 0,2 0,41  -0.01 ; 0.83 0.054 
SES 0.095  0.00 ; 0.19 0.039 0,1  0.02 ; 0.19 0.018 0.069  -0.03 ; 0.17 0,16 
 Adj R2: 0.034 Adj R2: 0.069 Adj R2: 0.026 
 p Model: 0.25 p Model: 0.13 p Model: 0.28 
Intercept 9,32  5.42 ; 13.21 < 0.0001 8,14  4.44 ; 11.84 < 0.0001 7,34  3.01 ; 11.68 0.001 
Temporal lobe 0.027  -0.00 ; 0.06 0.068 0.024  -0.00 ; 0.05 0.082 0,0012  -0.03 ; 0.03 0,94 
Sex -0,37  -0.81 ; 0.07 0.098 -0,27  -0.69 ; 0.15 0,2 -0.096  -0.59 ; 0.39 0,7 
PMA at MRI -0.029  -0.12 ; 0.06 0,52 -0.017  -0.10 ; 0.07 0,68 0.034  -0.06 ; 0.13 0,48 
MRI Cohort 0,22  -0.15 ; 0.60 0,24 0,26  -0.10 ; 0.61 0,15 0,41  -0.00 ; 0.83 0.052 
SES 0.087  -0.00 ; 0.18 0.052 0.097  0.01 ; 0.18 0.024 0.069  -0.03 ; 0.17 0,16 
 Adj R2: 0.093 Adj R2: 0.11 Adj R2: 0.026 
 p Model: 0.077 p Model: 0.051 p Model: 0.28 
Intercept 9,91  6.03 ; 13.79 < 0.0001 8,65  4.90 ; 12.40 < 0.0001 7,39  3.14 ; 11.65 0.001 
Cerebellum 0,04  -0.01 ; 0.09 0.099 0.017  -0.03 ; 0.06 0,47 0.022  -0.03 ; 0.07 0,4 
Sex -0,29  -0.71 ; 0.14 0,18 -0,17  -0.58 ; 0.24 0,4 -0,11  -0.58 ; 0.35 0,62 
PMA at MRI -0.037  -0.13 ; 0.06 0,42 -0,01  -0.10 ; 0.08 0,82 0.019  -0.08 ; 0.12 0,71 
MRI Cohort 0,16  -0.22 ; 0.55 0,4 0,23  -0.14 ; 0.60 0,22 0,38  -0.04 ; 0.80 0.078 
SES 0,11  0.02 ; 0.20 0.019 0,11  0.02 ; 0.20 0.013 0.075  -0.02 ; 0.17 0,13 
 Adj R2: 0.082 Adj R2: 0.066 Adj R2: 0.04 
 p Model: 0.097 p Model: 0.14 p Model: 0.22 
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Supplementary Table S4. Association between neonatal brain volume and one-
year neurodevelopmental outcome in healthy controls. Multiple linear regression 
models for total brain volume and each neurodevelopmental outcome domain in 
healthy controls. ß, ß coefficient of the covariates; CI, confidence interval; Adj, 
adjusted; TBV, total brain volume; PMA, postmenstrual age; MRI, magnetic resonance 
imaging; SES, socioeconomic status. p Model corresponds to p-value of the linear 
regression model.  
 Cognitive Composite Score Language Composite Score Motor Composite Score 
 ß 95 % CI p ß 95 % CI p ß 95 % CI p 
Intercept 8,47 1.68; 15.26 0.016 8,35 1.50; 15.20 0.019 9 1.65; 16.36 0.018 
TBV 0,0045 -0.00 ; 0.01 0,2 -0,00084 -0.01 ; 0.01 0,81 0,0014 -0.01 ; 0.01 0,71 
Sex -0,26 -0.70 ; 0.18 0,24 0,23 -0.22 ; 0.67 0,3 -0.053 -0.53 ; 0.43 0,82 
PMA at MRI 0,0077 -0.21 ; 0.22 0,94 0.051 -0.17 ; 0.27 0,63 -0,0047 -0.24 ; 0.23 0,97 
MRI Cohort -0,26 -0.67 ; 0.15 0,21 0,23 -0.18 ; 0.65 0,25 0,2 -0.24 ; 0.64 0,36 
SES 0.029 -0.11 ; 0.17 0,67 -0.048 -0.19 ; 0.09 0,48 0.062 -0.09 ; 0.21 0,4 
 Adj R2: 0.096 Adj R2: -0.077 Adj R2: -0.091 
 p Model: 0.18 p Model: 0.73 p Model: 0.79 
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Supplementary Table S5. Association between regional brain growth and one-
year neurodevelopmental outcome in CHD infants. Multiple linear regression 
models for total and regional brain growth in cm3/week and each neurodevelopmental 
outcome domain in CHD infants. ß, ß coefficient of the covariates; CI, confidence 
interval; Adj, adjusted; TBV, total brain volume; MRI, magnetic resonance imaging; 
SES, socioeconomic status. p Model corresponds to p-value of the linear regression 
model. 
 Cognitive Composite Score 
Language Composite 
Score 
Motor Composite Score 
 ß 95 % CI p ß 95 % CI p ß 95 % CI p 
Intercept 9.69 8.75 ; 10.63 
< 
0.0001 
8,59 7.66 ; 9.52 
< 
0.0001 
8,86 7.89 ; 9.84 
< 
0.0001 
Total brain growth -0.001 -0.01 ; 0.01 0.85 -0.005 -0.02 ; 0.01 0,37 0.001 -0.01 ; 0.01 0,86 
Sex -0.14 -0.62 ; 0.33 0.55 -0.036 -0.50 ; 0.43 0,88 0,00043 -0.49 ; 0.49 1 
MRI Cohort 0.23 -0.18 ; 0.63 0.27 0,29 -0.12 ; 0.69 0,16 0,39 -0.04 ; 0.81 0.073 
SES 0.079 -0.02 ; 0.17 0.098 0,11 0.02 ; 0.21 0.017 0.065 -0.03 ; 0.16 0,19 
 Adj R2: 0.0038 Adj R2: 0.084 Adj R2: 0.018 
 p Model: 0.39 p Model: 0.092 p Model: 0.31 
Intercept 9,69 8.75 ; 10.64 
< 
0.0001 
8,61 7.69 ; 9.53 
< 
0.0001 
8,86 7.88 ; 9.84 
< 
0.0001 
Cortical growth -0,0029 -0.02 ; 0.01 0,67 
-
0,0076 
-0.02 ; 0.01 0,26 0,0017 -0.01 ; 0.02 0,81 
Sex -0,13 -0.60 ; 0.33 0,57 -0.036 -0.49 ; 0.42 0,88 
-
0,00049 
-0.49 ; 0.48 1 
MRI Cohort 0,22 -0.19 ; 0.63 0,28 0,28 -0.12 ; 0.68 0,17 0,39 -0.04 ; 0.81 0.072 
SES 0.079 -0.01 ; 0.17 0.096 0,11 0.02 ; 0.21 0.017 0.065 -0.03 ; 0.16 0,19 
 Adj R2: 0.0071 Adj R2: 0.094 Adj R2: 0.019 
 p Model: 0.37 p Model: 0.076 p Model: 0.31 
Intercept 9,69 8.74 ; 10.64 
< 
0.0001 
8,56 7.62 ; 9.50 
< 
0.0001 
8,86 7.87 ; 9.85 
< 
0.0001 
White matter 
growth 
0,0007 -0.02 ; 0.02 0,95 
-
0,0071 
-0.03 ; 0.01 0,49 -0,0004 -0.02 ; 0.02 0,97 
Sex -0,16 -0.64 ; 0.31 0,5 -0.051 -0.52 ; 0.42 0,83 0.016 -0.48 ; 0.51 0,95 
MRI Cohort 0,23 -0.18 ; 0.64 0,27 0,28 -0.13 ; 0.69 0,17 0,38 -0.04 ; 0.81 0.077 
SES 0.078 -0.02 ; 0.17 0,11 0,12 0.02 ; 0.21 0.016 0.066 -0.03 ; 0.16 0,19 
 Adj R2: 0.0031 Adj R2: 0.078 Adj R2: 0.018 
 p Model: 0.40 p Model: 0.11 p Model: 0.31 
Intercept 9,69 8.75 ; 10.63 
< 
0.0001 
8,59 7.66 ; 9.53 
< 
0.0001 
8,86 7.88 ; 9.84 
< 
0.0001 
Frontal lobe 
growth 
0,00034 -0.04 ; 0.04 0,99 -0.012 -0.05 ; 0.03 0,56 0,0017 -0.04 ; 0.05 0,94 
Sex -0,16 -0.62 ; 0.31 0,5 -0.067 -0.53 ; 0.40 0,77 0.009 -0.48 ; 0.49 0,97 
MRI Cohort 0,23 -0.18 ; 0.63 0,27 0,29 -0.11 ; 0.70 0,15 0,38 -0.04 ; 0.81 0.074 
SES 0.078 -0.02 ; 0.17 0,1 0,11 0.02 ; 0.21 0.018 0.065 -0.03 ; 0.16 0,19 
 Adj R2: 0.0030 Adj R2: 0.075 Adj R2: 0.018 
 p Model: 0.40 p Model: 0.11 p Model: 0.31 
Intercept 9,67 8.72 ; 10.62 
< 
0.0001 
8,54 7.61 ; 9.48 
< 
0.0001 
8,85 7.86 ; 9.83 
< 
0.0001 
Parietal lobe 
growth 
-0,0081 -0.06 ; 0.05 0,76 -0.025 -0.08 ; 0.03 0,34 -0,0074 -0.06 ; 0.05 0,79 
Sex -0,13 -0.61 ; 0.35 0,58 -0.023 -0.50 ; 0.45 0,92 0.036 -0.46 ; 0.54 0,89 
MRI Cohort 0,22 -0.20 ; 0.63 0,3 0,26 -0.14 ; 0.67 0,2 0,37 -0.05 ; 0.80 0.086 
SES 0,08 -0.01 ; 0.18 0.094 0,12 0.02 ; 0.21 0.014 0.067 -0.03 ; 0.17 0,18 
 Adj R2: 0.0050 Adj R2: 0.087 Adj R2: 0.020 
 p Model: 0.39 p Model: 0.088 p Model: 0.31 
Intercept 9,7 8.76 ; 10.64 
< 
0.0001 
8,59 7.65 ; 9.52 
< 
0.0001 
8,87 7.89 ; 9.85 
< 
0.0001 
Occipital lobe 
growth 
0.016 -0.06 ; 0.09 0,66 -0.017 -0.09 ; 0.05 0,64 0.013 -0.06 ; 0.09 0,73 
Sex -0,18 -0.64 ; 0.28 0,44 -0.075 -0.54 ; 0.39 0,75 -0,0054 -0.49 ; 0.48 0,98 
MRI Cohort 0,24 -0.17 ; 0.65 0,25 0,28 -0.12 ; 0.69 0,17 0,39 -0.03 ; 0.82 0,07 
SES 0.076 -0.02 ; 0.17 0,11 0,11 0.02 ; 0.21 0.018 0.064 -0.03 ; 0.16 0,2 
 Adj R2: 0.0074 Adj R2: 0.073 Adj R2: 0.021 
 p Model: 0.37 p Model: 0.12 p Model: 0.30 
Intercept 9,68 8.74 ; 10.62 
< 
0.0001 
8,61 7.69 ; 9.54 
< 
0.0001 
8,85 7.88 ; 9.83 
< 
0.0001 
Temporal lobe 
growth 
0.015 -0.06 ; 0.09 0,67 -0.035 -0.11 ; 0.04 0,32 0.023 -0.05 ; 0.10 0,53 
Sex -0,19 -0.66 ; 0.29 0,43 -0.031 -0.50 ; 0.43 0,89 -0.031 -0.52 ; 0.46 0,9 
MRI Cohort 0,23 -0.17 ; 0.64 0,25 0,28 -0.12 ; 0.68 0,17 0,4 -0.03 ; 0.82 0.066 
SES 0.078 -0.02 ; 0.17 0,1 0,11 0.02 ; 0.21 0.017 0.064 -0.03 ; 0.16 0,19 
 Adj R2: 0.0070 Adj R2: 0.089 Adj R2: 0.027 
 p Model: 0.37 p Model: 0.085 p Model: 0.27 
Intercept 9,71 8.76 ; 10.65 
< 
0.0001 
8,58 7.65 ; 9.52 
< 
0.0001 
8,87 7.89 ; 9.85 
< 
0.0001 
Cerebellar growth 0.033 -0.09 ; 0.16 0,59 -0.027 -0.15 ; 0.10 0,67 0,0079 -0.12 ; 0.14 0,9 
Sex -0,2 -0.69 ; 0.28 0,4 -0.061 -0.54 ; 0.42 0,8 0,0024 -0.50 ; 0.51 0,99 
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MRI Cohort 0,24 -0.17 ; 0.65 0,25 0,29 -0.12 ; 0.69 0,16 0,39 -0.04 ; 0.81 0.074 
SES 0.075 -0.02 ; 0.17 0,12 0,11 0.02 ; 0.21 0.018 0.064 -0.03 ; 0.16 0,19 
 Adj R2: 0.0094 Adj R2: 0.072 Adj R2: 0.018 
 p Model: 0.36 p Model: 0.12 p Model: 0.31 
 
Supplementary Table S6. Association between postoperative neonatal brain 
volume and one-year neurodevelopmental outcome in CHD infants. Multiple 
linear regression models for each respective postoperative regional brain volume and 
neurodevelopmental outcome domain in CHD infants. ß, ß coefficient of the 
covariates; CI, confidence interval; Adj, adjusted; TBV, total brain volume; PMA, 
postmenstrual age; MRI, magnetic resonance imaging; SES, socioeconomic status. p 
Model corresponds to p-value of the linear regression model. P values of brain 
volumes independently associated with outcome are printed in bold. 
 
 Cognitive Composite Score Language Composite Score Motor Composite Score 
 ß 95% CI p ß 95% CI p ß 95% CI p 
Intercept 7,33 3.35 ; 11.31 0,0005 7,62 3.91 ; 11.32 0,0001 3,94 -0.02 ; 7.90 0.051 
TBV 0,0065 0.00 ; 0.01 0.037 0,0061 0.00 ; 0.01 0.037 0,0048 -0.00 ; 0.01 0,12 
Sex -0,33 -0.85 ; 0.18 0,2 -0,34 -0.82 ; 0.15 0,17 -0,16 -0.67 ; 0.36 0,54 
PMA at MRI -0,0046 -0.11 ; 0.10 0,93 -0,03 -0.13 ; 0.07 0,54 0.069 -0.03 ; 0.17 0,18 
MRI Cohort -0.022 -0.42 ; 0.38 0,91 0,2 -0.18 ; 0.57 0,3 0,26 -0.14 ; 0.65 0,2 
SES 0.095 0.00 ; 0.19 0.049 0,12 0.03 ; 0.21 0.013 0.085 -0.01 ; 0.18 0.076 
 Adj. R2: 0.11 Adj R2: 0.15 Adj R2: 0.15 
 p Model: 0.049  p Model: 0.017  p Model: 0.018  
Intercept 8,47 4.34 ; 12.61 0,0001 8,66 4.80 ; 12.52 < 0.0001 4,86 0.74 ; 8.97 0.022 
Cortex 0,0092 0.00 ; 0.02 0.027 0,0084 0.00 ; 0.02 0.031 0,0073 -0.00 ; 0.02 0.075 
Sex -0,34 -0.84 ; 0.17 0,19 -0,33 -0.81 ; 0.14 0,17 -0,17 -0.67 ; 0.33 0,5 
PMA at MRI -0.028 -0.14 ; 0.08 0,62 -0,05 -0.16 ; 0.06 0,34 0.047 -0.06 ; 0.16 0,4 
MRI Cohort -0,14 -0.57 ; 0.28 0,5 0.085 -0.32 ; 0.49 0,67 0,16 -0.26 ; 0.58 0,46 
SES 0.095 0.00 ; 0.19 0.049 0,12 0.03 ; 0.21 0.011 0.084 -0.01 ; 0.18 0.078 
 Adj R2: 0.12 Adj R2: 0.16 Adj R2: 0.16 
 p Model: 0.039  p Model: 0.015  p Model: 0.013  
Intercept 5,79 1.64 ; 9.94 0.007 6,26 2.37 ; 10.16 0.002 2,77 -1.36 ; 6.90 0,18 
White matter 0.012 0.00 ; 0.02 0.036 0,01 -0.00 ; 0.02 0.057 0,0093 -0.00 ; 0.02 0,11 
Sex -0,31 -0.81 ; 0.19 0,23 -0,3 -0.78 ; 0.18 0,21 -0,14 -0.63 ; 0.36 0,58 
PMA at MRI 0.033 -0.06 ; 0.12 0,46 0,0082 -0.08 ; 0.09 0,85 0.097 0.01 ; 0.19 0.035 
MRI Cohort 0,18 -0.24 ; 0.60 0,39 0,38 -0.02 ; 0.78 0,06 0,41 -0.01 ; 0.83 0.055 
SES 0.089 -0.01 ; 0.18 0.068 0,11 0.02 ; 0.21 0.019 0,08 -0.02 ; 0.18 0.097 
 Adj R2: 0.11 Adj R2: 0.14 Adj R2: 0.15 
 p Model: 0.047 p Model: 0.023 p Model: 0.017 
Intercept 6,25 2.23 ; 10.27 0.003 6,56 2.83 ; 10.28 0,0009 3,13 -0.88 ; 7.14 0,12 
Frontal lobe 0.022 0.00 ; 0.04 0.027 0.022 0.00 ; 0.04 0,02 0.017 -0.00 ; 0.04 0.092 
Sex -0,31 -0.81 ; 0.18 0,21 -0,33 -0.80 ; 0.13 0,16 -0,14 -0.63 ; 0.35 0,57 
PMA at MRI 0.021 -0.07 ; 0.11 0,65 -0,0067 -0.09 ; 0.08 0,88 0.088 -0.00 ; 0.18 0.062 
MRI Cohort 0.048 -0.35 ; 0.44 0,81 0,27 -0.10 ; 0.64 0,15 0,31 -0.09 ; 0.70 0,12 
SES 0.093 -0.00 ; 0.19 0.053 0,11 0.02 ; 0.20 0.015 0.084 -0.01 ; 0.18 0.081 
 Adj R2: 0.12 Adj R2: 0.17 Adj R2: 0.15 
 p Model: 0.039  p Model: 0.011  p Model: 0.015  
Intercept 6,63 2.61 ; 10.65 0.002 7,08 3.27 ; 10.90 0,0005 3,39 -0.59 ; 7.37 0.094 
Parietal lobe 0.027 -0.00 ; 0.05 0.052 0.018 -0.01 ; 0.04 0,18 0.022 -0.01 ; 0.05 0,11 
Sex -0,28 -0.77 ; 0.22 0,27 -0,23 -0.71 ; 0.25 0,34 -0,12 -0.62 ; 0.37 0,61 
PMA at MRI 0.023 -0.07 ; 0.12 0,63 0,0047 -0.08 ; 0.09 0,92 0.088 -0.01 ; 0.18 0.064 
MRI Cohort 0,14 -0.28 ; 0.55 0,51 0,32 -0.08 ; 0.72 0,11 0,38 -0.03 ; 0.79 0.068 
SES 0.094 -0.00 ; 0.19 0.053 0,12 0.03 ; 0.22 0.012 0.084 -0.01 ; 0.18 0.082 
 Adj R2: 0.097 Adj R2: 0.11 Adj R2: 0.15 
 p Model: 0.061  p Model: 0.048  p Model: 0.017  
Intercept 7,2 3.19 ; 11.22 0,0007 7,5 3.75 ; 11.25 0,0002 3,86 -0.09 ; 7.81 0.055 
Occipital lobe 0,05 -0.01 ; 0.11 0.077 0.046 -0.01 ; 0.10 0.086 0.046 -0.01 ; 0.10 0,1 
Sex -0,22 -0.70 ; 0.27 0,37 -0,23 -0.69 ; 0.23 0,32 -0.093 -0.57 ; 0.38 0,7 
PMA at MRI 0.015 -0.08 ; 0.11 0,77 -0.011 -0.10 ; 0.08 0,82 0.077 -0.02 ; 0.17 0,12 
MRI Cohort 0,0023 -0.40 ; 0.40 0,99 0,22 -0.16 ; 0.60 0,25 0,27 -0.12 ; 0.67 0,18 
SES 0.091 -0.01 ; 0.19 0.068 0,12 0.02 ; 0.21 0.017 0.078 -0.02 ; 0.17 0,11 
 Adj R2: 0.086 Adj R2: 0.13 Adj R2: 0.15 
 p Model: 0.078  p Model: 0.031  p Model: 0.016  
Intercept 6.87 3.00 ; 10.75 0.0008 7.21 3.51 ; 10.91 0.0003 3.64 -0.33 ; 7.60 0.072 
Temporal lobe 0.044 0.01 ; 0.08 0.008 0.033 0.00 ; 0.06 0.035 0.024 -0.01 ; 0.06 0.14 
Sex -0.39 -0.89 ; 0.10 0.12 -0.33 -0.81 ; 0.15 0.17 -0.14 -0.65 ; 0.37 0.59 
PMA at MRI -
0.00061 
-0.10 ; 0.09 0.99 -0.016 -0.11 ; 0.07 0.73 0.082 -0.02 ; 0.18 0.096 
MRI Cohort 0.046 -0.34 ; 0.43 0.81 0.27 -0.11 ; 0.64 0.16 0.3 -0.09 ; 0.70 0.13 
SES 0.09 -0.00 ; 0.18 0.058 0.11 0.02 ; 0.20 0.017 0.085 -0.01 ; 0.18 0.077 
 Adj R2: 0.15 Adj R2: 0.15 Adj R2: 0.14 
 p Model: 0.016  p Model: 0.016  p Model: 0.020  
Intercept 7,98 4.00 ; 11.97 0,0002 8 4.19 ; 11.81 < 0.0001 4,41 0.42 ; 8.41 0.031 
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Cerebellum 0,06 0.01 ; 0.11 0.017 0.041 -0.01 ; 0.09 0.081 0.044 -0.00 ; 0.09 0.077 
Sex -0,24 -0.70 ; 0.22 0,31 -0,23 -0.68 ; 0.23 0,33 -0.083 -0.55 ; 0.38 0,72 
PMA at MRI -0.011 -0.11 ; 0.09 0,83 -0,02 -0.12 ; 0.08 0,69 0.065 -0.04 ; 0.17 0,2 
MRI Cohort -0.052 -0.45 ; 0.34 0,79 0,2 -0.19 ; 0.58 0,31 0,23 -0.16 ; 0.63 0,24 
SES 0,11 0.01 ; 0.20 0.026 0,13 0.04 ; 0.22 0.006 0.093 0.00 ; 0.19 0.048 
 Adj R2: 0.13 Adj R2: 0.13 Adj R2: 0.16 
 p Model: 0.028  p Model: 0.029  p Model: 0.013  
 
Supplementary Note 
Validation of the atlas prior based volumetry method 
Patient population 
We validated two approaches for automatic brain volumetry: atlas prior based 
estimation (unpublished method used for testing the main hypothesis of this 
manuscript) and an expectation maximization based algorithm, implemented in the 
processing pipeline of the developing human connectome project dHCP (Makropoulos 
et al., 2014). Three different, overlapping subsets of the total study population were 
used for validation (Supplementary Table S7). 
Supplementary Table S7. Basic demographic data of the validation sub-
populations. Sub-set 3 is part of sub-set 2, and sub-set 2 is part of sub-set 1. CHD: 
congenital heart defect 
 
Sub-set 1: 
Automatic 
volumetry 
validation dataset 
Sub-set 2: Manual 
stereology of 
cerebellum, total brain 
volume and 
intracranial volume 
Sub-set 3: 
Stereology incl. 
cortex and white 
matter volumes 
Number of cases 52 40 28 
Male/female 34/18 28/12 17/11 
CHD / controls 35/17 30/10 18/10 
Corrected gestational age 
at time of MRI 
(weeks, mean ± SD, 
range) 
41.4 ± 2.1,  
37.6 – 46.2 
41.2 ± 1.9,  
37.6 – 45.1 
41.3 ± 1.9,  
38.1 – 45.1 
Image processing 
The validation was carried out on the reconstructed 3D T2 images. First, non-brain 
tissue parts of the axial, coronal and sagittal T2-weighted images were removed by 
applying image masks generated from an age-specific neonatal neuroanatomical atlas. 
The masked, axial and coronal images were co-registered to the sagittal image using 
a mutual information based affine and non-linear registration as implemented in the 
Niftireg image registration package (Modat et al., 2010). Bias field correction of the 
images was performed by the N4ITK filter in the Slicer 3D software (Fedorov et al., 
2012), and the three orthogonal resolution images were resampled to form a joint, high-
resolution image. Examples for the reconstructed images and segmentations are given 
in the main manuscript. 
Automatic segmentation by non-linear transformation of anatomical priors 
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Anatomical priors from the ALBERTs1 data set, which is gestational age-specific 
neonatal anatomical atlas (Gousias et al., 2012), were matched to the subjects 
reconstructed images using a linear affine registration (flirt in FSL) followed by a fast 
freeform non-linear deformation (reg_f3d command in the Niftireg software), based on 
the algorithm of Modal et al. 2010. The algorithm uses cubic B-spline to deform a 
source image in order to optimise an objective function based on the normalized mutual 
information and a penalty term. The penalty term used was the bending energy. 
The parameters of the non-linear registration were the following: 
 Grid spacing along the x,y,z directions: 8 * 8 * 8 mm 
 Penalty term: bending energy=0.005 
The anatomical masks of the supratentorial white matter, grey matter (cortex only) and 
lobar subdivisions of the supratentorial white matter (frontal, parietal, temporal and 
occipital lobe) were matched to the T2-weighted super-resolution images. A whole-
brain mask was defined to include the diencephalon, cortical mantle, supratentorial 
white matter, but not the intra- and extra axial cerebrospinal fluid spaces or cerebellum. 
The patient-specific priors were thresholded at 50 % probability, and their volume was 
stored for the statistical evaluations. 
Validation using the automatic segmentation by dHCP pipeline 
The dHCP structural pipeline was used to automatically segment the neonatal brain 
(Makropoulos et al., 2018). This pipeline is a fully automated processing pipeline for 
T1 and T2 weighted neonate brain MRI images. The pipeline performs cortical and 
sub-cortical volume segmentation, cortical surface extraction, and cortical surface 
inflation. The segmentation is based on an adaptive Expectation-Maximization 
algorithm (Makropoulos et al., 2014, 2016). 
Manual volumetry 
Manual validation was performed by stereology using the EasyMeasure software 
package (Puddephat, 1999), following a method that has previously been described 
in detail elsewhere (Mayer et al., 2016). During stereology, a random grid is overlaid 
on the MR image, and the user assigns a label to each grid point that belongs to a 
given structure (Supplementary Figure S2). 
                                                     
1 Copyright Imperial College of Science, Technology and Medicine and Ioannis S. Gousias 2013. All rights reserved. 
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Supplementary Figure S2. Manual volume estimation by stereology in the 
EasyMeasure software. Grid points are displayed in red, overlaid on a T2-weighted 
neonatal MR image. (Illustration not actually used for measurement) 
Correlations and overlaps of regional volumes across methods 
The agreement of the two automated volumetry approaches with ground truth 
manual stereology data was tested by calculating the correlation coefficient 
(Supplementary Table S8).  
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Supplementary Table S8. Estimation of regional brain volumes and correlations 
with manual, ground truth stereology. 
Region, method Correlation coefficient 
(Pearson’s r) 
Significance (p) 
Total brain volume, Atlas1 0.930 4.56*10-18 
Cerebellum, Atlas1 0.827 4.89*10-11 
Cortex, Atlas1 0.881 6.27*10-10 
White matter, Atlas1 0.675 0.000111 
Cerebellum, dHCP2 0.914 4.53*10-16 
Cortex, dHCP2 0.954 1.18*10-15 
White matter, dHCP2 0.566 0.002 
1: Atlas prior based approach, used during the main hypothesis test. 
2: Method by Makropoulos et al. 
 
As stereology does not result in binarized label maps, we were only able to calculate 
the spatial overlaps between the two automated approaches. Volumetric overlap was 
estimated as the Dice coefficient (%) of the subject-matched anatomical priors 
(binarized at 50%) and the transformed label maps of the dHCP pipeline. Table S2/3. 
summarizes the accuracy of the atlas prior based approach to the dHCP pipeline and 
manual stereology. 
Supplementary Table S9. Correlation of volume estimates and spatial overlaps 
with the atlas prior based approach. 
Region, method Correlation of volume 
estimates (Pearson’s 
r) 
Correlation of 
volume estimates, 
significance (p) 
Volumetric 
overlap (Dice 
coefficient, %) 
Cerebellum, dHCP1 0.940 1.53*10-24 90.7 ± 2.2 
Cortex, dHCP1 0.877 3.44*10-17 74.1 ± 2.6 
White matter, dHCP1 0.745 3.67*10-10 80.4 ± 2.4 
Cerebellum, Manual 0.856 3.55*10-12 - 
Cortex, Manual 0.881 6.27*10-10 - 
White matter, Manual 0.675 0.000111 - 
Frontal WM, dHCP1 0.511 0.000108 82.7 ± 3.2 
Parietal WM, dHCP1 0.547 0.000028 76.4 ± 6.3 
Temporal WM, dHCP1 0.887 4.54*10-18 72.7 ± 2.8 
Occipital WM, dHCP1 0.737 4.54*10-10 72.4 ± 3.4 
1: Method by Makropoulos et al. 
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CHD / control volumetric ratios 
We tested whether the CHD to control ratio depends on the utilized segmentation or 
stereology approach (Figure S3).   
 
Supplementary Figure S3. Comparison of the CHD-to-normal brain volume 
ratios across methods. Lobar volumes refer to lobar white matter volumes. 
 
Validation of the atlas prior based approach - summary 
The anatomical atlas prior based segmentation and the dHCP pipeline gives 
comparable and faithful volumetry results for the cortex, total brain and cerebellar 
volume. The cortex and white matter volumes show larger variability, and less faithful 
estimation of the biologically relevant CHD/normal volume ratio. The volumes of lobar 
subdivisions show substantial differences between the methods (correlation coefficient 
0.511-0.887), however, this could stem from the different anatomical definition of the 
deep white matter borders of the lobes in the two parcellation schemes. Despite the 
lower correlation of the lobar volumes, the corresponding CHD-to-normal ratios are 
remarkably similar between the two methods (difference: <2 %), while the cortex / white 
matter boundaries differed between these methods by a margin of 3-7%. The high 
variability of cortical volumes by both automated approaches limit the generalisability 
of the volumetric findings, and more reliable and reproducible results can be expected 
for lobar white matter, total brain volume and cerebellar volume estimates. 
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Supplementary Figure S4. Growth trajectories of brain tissue subvolumes and 
cerebellum of CHD infants compared to controls. Left images: linear regression 
plots. Red dots: brain volume of controls, Red line: cross-sectional brain growth of 
the controls. Black circles: preoperative brain volume of the CHD infants. 
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Supplementary Figure S5. Growth trajectories of lobar white matter volumes of 
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CHD infants compared to controls. Left images: linear regression plots. Red dots: 
brain volume of controls, Red line: cross-sectional brain growth of the controls. Black 
circles: preoperative brain volume of the CHD infants. 
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